Aura Biosciences (AURA) Accumulated Expenses (2020 - 2026)

Aura Biosciences' Accumulated Expenses history runs 7 years deep, the most recent figure standing at $10.9 million for Q1 2026.

• Quarterly Accumulated Expenses rose 293.27% year-over-year to $10.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.9 million (up 293.27% YoY) and the FY2025 annual result came in at $13.6 million, up 149.1% from the prior year.
• Accumulated Expenses was $10.9 million for Q1 2026 at Aura Biosciences, down from $13.6 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $13.6 million in Q4 2025 and bottomed at $2.4 million in Q1 2022.
• A 5-year average of $5.7 million and a median of $5.0 million in 2024 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2023 — Accumulated Expenses sank 44.83% — and 2026, when it jumped 293.27%.
• Aura Biosciences' Accumulated Expenses stood at $4.6 million in 2022, then fell by 23.4% to $3.5 million in 2023, then surged by 55.75% to $5.5 million in 2024, then surged by 149.1% to $13.6 million in 2025, then retreated by 20.05% to $10.9 million in 2026.
• Business Quant data shows AURA's Accumulated Expenses at $10.9 million in Q1 2026, $13.6 million in Q4 2025, and $6.1 million in Q3 2025.